Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of escherichia coli and proteus mirabilis harbouring known β-lactamases
Infection1991Vol. 19(2), pp. 106–109
Citations Over Time
Related Papers
- → Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin(1984)123 cited
- → Tazobactam is a potent inactivator of selected inhibitor-resistant class A β-lactamases(2006)44 cited
- → Penetration of β-lactamase inhibitors into the periplasm of Gram-negative bacteria(1999)21 cited
- → Activity of 13 β-lactam agents combined with BRL 42715 against β-lactamase producing Gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam(1993)17 cited
- Study on in vitro Antibacterial Activity of Cefperazone/Tazobactam(2001)